G. F. Lewis and D. J. Rader, New insights into the regulation of HDL metabolism and reverse cholesterol transport, Circ Res, vol.96, pp.1221-1232, 2005.

A. D. Watson, M. Navab, S. Y. Hama, A. Sevanian, S. M. Prescott et al.,

B. N. Mcintyre, A. M. Du, J. A. Fogelman, and . Berliner, Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein, J Clin Invest, vol.95, pp.774-782, 1995.

A. D. Watson, J. A. Berliner, S. Y. Hama, B. N. Du, K. F. Faull et al., Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein, J Clin Invest, vol.96, pp.2882-2891, 1995.

M. I. Mackness, S. Arrol, and P. N. Durrington, Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein, FEBS Lett, vol.286, pp.152-154, 1991.

B. J. Van-lenten, S. Y. Hama, F. C. De-beer, D. M. Stafforini, T. M. Mcintyre et al., Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures, J Clin Invest, vol.96, pp.2758-2767, 1995.

R. A. Memon, I. Staprans, M. Noor, W. M. Holleran, Y. Uchida et al., Infection and inflammation induce LDL oxidation in vivo, Arterioscler Thromb Vasc Biol, vol.20, pp.1536-1542, 2000.

J. L. Witztum and D. Steinberg, Role of oxidized low density lipoprotein in atherogenesis, J Clin Invest, vol.88, pp.1785-1792, 1991.

A. M. Barcia and H. W. Harris, Triglyceride-rich lipoproteins as agents of innate immunity, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 41, vol.7, pp.498-503, 2005.

R. Bartenschlager, F. Penin, V. Lohmann, and P. Andre, Assembly of infectious hepatitis C virus particles, Trends in microbiology, vol.19, pp.95-103, 2011.

R. M. Steinman and H. Hemmi, Dendritic cells: translating innate to adaptive immunity, Current topics in microbiology and immunology, vol.311, pp.17-58, 2006.

A. Mazzoni and D. M. Segal, Controlling the Toll road to dendritic cell polarization, J Leukoc Biol, vol.75, pp.721-730, 2004.

L. Perrin-cocon, F. Coutant, S. Agaugue, S. Deforges, P. Andre et al., Oxidized lowdensity lipoprotein promotes mature dendritic cell transition from differentiating monocyte, J Immunol, vol.167, pp.3785-3791, 2001.
URL : https://hal.archives-ouvertes.fr/inserm-00136264

F. Coutant, L. Perrin-cocon, S. Agaugue, T. Delair, P. Andre et al., Mature dendritic cell generation promoted by lysophosphatidylcholine, J Immunol, vol.169, pp.1688-1695, 2002.
URL : https://hal.archives-ouvertes.fr/inserm-00136347

C. J. Alderman, P. R. Bunyard, B. M. Chain, J. C. Foreman, D. S. Leake et al., Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment?, Cardiovascular research, vol.55, pp.806-819, 2002.

T. Nickel, D. Schmauss, H. Hanssen, Z. Sicic, B. Krebs et al., oxLDL uptake by dendritic cells induces upregulation of scavengerreceptors, maturation and differentiation, Atherosclerosis, vol.205, pp.442-450, 2009.

M. Luchtefeld, C. Grothusen, A. Gagalick, K. Jagavelu, H. Schuett et al.,

H. Grote, R. Drexler, B. Forster, and . Schieffer, Chemokine receptor 7 knockout attenuates atherosclerotic plaque development, Circulation, vol.122, pp.1621-1628, 2010.

J. Ge, H. Yan, S. Li, W. Nie, K. Dong et al., Changes in proteomics profile during maturation of marrow-derived dendritic cells treated with oxidized lowdensity lipoprotein, Proteomics, vol.11, pp.1893-1902, 2011.

L. H. Shen, L. Zhou, B. Y. Wang, J. Pu, L. H. Hu et al., Oxidized low-density lipoprotein induces differentiation of RAW264.7 murine macrophage cell line into dendritic-like cells, Atherosclerosis, vol.199, pp.257-264, 2008.

H. J. Cho, P. Shashkin, C. A. Gleissner, D. Dunson, N. Jain et al., Induction of dendritic cell-like phenotype in macrophages during foam cell formation, Physiological genomics, vol.29, pp.149-160, 2007.

S. Parthasarathy and J. Barnett, Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apoprotein B-100, Proc Natl Acad Sci U S A, vol.87, pp.9741-9745, 1990.

U. P. Steinbrecher and P. H. Pritchard, Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase, J Lipid Res, vol.30, pp.305-315, 1989.

S. Kunnen and M. Van-eck, Lecithin-cholesterol acyltransferase: old friend or foe in atherosclerosis?, J Lipid Res, 2012.

V. S. Subramanian, J. Goyal, M. Miwa, J. Sugatami, M. Akiyama et al., Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma, Biochim Biophys Acta, vol.1439, pp.95-109, 1999.

H. Itabe, R. Hosoya, K. Karasawa, S. Jimi, K. Saku et al., Metabolism of oxidized phosphatidylcholines formed in oxidized low density lipoprotein by lecithincholesterol acyltransferase, Journal of biochemistry, vol.126, pp.153-161, 1999.

W. Pruzanski, L. Lambeau, M. Lazdunsky, W. Cho, J. Kopilov et al., Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A(2), Biochim Biophys Acta, vol.1736, pp.38-50, 2005.

K. Yamamoto, Y. Isogai, H. Sato, Y. Taketomi, and M. Murakami, Secreted phospholipase A2, lipoprotein hydrolysis, and atherosclerosis: integration with lipidomics, Anal Bioanal Chem, vol.400, pp.1829-1842, 2011.

R. Atout, S. A. Karabina, S. Dollet, M. Carreras, C. Payre et al., Human group X secreted phospholipase A(2) induces dendritic cell maturation through lipoprotein-dependent and -independent mechanisms, Atherosclerosis, vol.222, pp.367-374, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00731327

M. T. Quinn, S. Parthasarathy, and D. Steinberg, Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis, Proc Natl Acad Sci U S A, vol.85, pp.2805-2809, 1988.

K. Lauber, S. G. Blumenthal, M. Waibel, and S. Wesselborg, Clearance of apoptotic cells: getting rid of the corpses, Mol Cell, vol.14, pp.277-287, 2004.

H. F. Mcmurray, S. Parthasarathy, and D. Steinberg, Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes, J Clin Invest, vol.92, pp.1004-1008, 1993.

C. G. Radu, L. V. Yang, M. Riedinger, M. Au, and O. N. Witte, T cell chemotaxis to lysophosphatidylcholine through the G2A receptor, Proc Natl Acad Sci U S A, vol.101, pp.245-250, 2004.

Q. Jing, S. M. Xin, W. B. Zhang, P. Wang, Y. W. Qin et al., Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis, Circ Res, vol.87, pp.52-59, 2000.

S. S. Ousman and S. David, Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord, Glia, vol.30, pp.92-104, 2000.

T. Ogita, Y. Tanaka, T. Nakaoka, R. Matsuoka, Y. Kira et al., Lysophosphatidylcholine transduces Ca2+ signaling via the platelet-activating factor receptor in macrophages, Am J Physiol, vol.272, pp.17-24, 1997.

J. Oestvang, M. W. Anthonsen, and B. Johansen, Role of secretory and cytosolic phospholipase A(2) enzymes in lysophosphatidylcholine-stimulated monocyte arachidonic acid release, FEBS Lett, vol.555, pp.257-262, 2003.

B. Z. Ngwenya and N. Yamamoto, Activation of peritoneal macrophages by lysophosphatidylcholine, Biochim Biophys Acta, vol.839, pp.9-15, 1985.

A. K. Ryborg, B. Deleuran, H. Sogaard, and K. Kragballe, Intracutaneous injection of lysophosphatidylcholine induces skin inflammation and accumulation of leukocytes, Acta Derm Venereol, vol.80, pp.242-246, 2000.

B. Z. Ngwenya and D. M. Foster, Enhancement of antibody production by lysophosphatidylcholine and alkylglycerol, Proc Soc Exp Biol Med, vol.196, pp.69-75, 1991.

L. Perrin-cocon, S. Agaugue, F. Coutant, P. Saint-mezard, A. Guironnet-paquet et al., Lysophosphatidylcholine is a natural adjuvant that initiates cellular immune responses, Vaccine, vol.24, pp.1254-1263, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00137028

G. Bach, L. Perrin-cocon, E. Gerossier, A. Guironnet-paquet, V. Lotteau et al., Single lysophosphatidylcholine components exhibit adjuvant activities in vitro and in vivo, Clinical and vaccine immunology : CVI, vol.17, pp.429-438, 2010.

B. Arnold, F. G. Staber, and J. F. Miller, Lysolecithin analogs as adjuvants in delayed-type hypersensitivity in mice. II. Studies on the mode of action, Eur J Immunol, vol.9, pp.367-370, 1979.

B. Arnold, J. F. Miller, and H. U. Weltzien, Lysolecithin analogs as adjuvants in delayed-type hypersensitivity in mice. I. Characterization of the adjuvant effect, Eur J Immunol, vol.9, pp.363-366, 1979.

F. Coutant, S. Agaugue, L. Perrin-cocon, P. Andre, and V. Lotteau, Sensing environmental lipids by dendritic cell modulates its function, J Immunol, vol.172, pp.54-60, 2004.
URL : https://hal.archives-ouvertes.fr/inserm-00136798

S. Bluml, S. Kirchberger, V. N. Bochkov, G. Kronke, K. Stuhlmeier et al.,

W. Zlabinger, B. R. Knapp, J. Binder, N. Stockl, and . Leitinger, Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40, J Immunol, vol.175, pp.501-508, 2005.

C. Erridge, D. J. Webb, and C. M. Spickett, Toll-like receptor 4 signalling is neither sufficient nor required for oxidised phospholipid mediated induction of interleukin-8 expression, Atherosclerosis, vol.193, pp.77-85, 2007.

C. Erridge, S. Kennedy, C. M. Spickett, and D. J. Webb, Oxidized phospholipid inhibition of tolllike receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition, J Biol Chem, vol.283, pp.24748-24759, 2008.

R. A. Daynes and D. C. Jones, Emerging roles of PPARs in inflammation and immunity, Nat Rev Immunol, vol.2, pp.748-759, 2002.

A. Nencioni, F. Grunebach, A. Zobywlaski, C. Denzlinger, W. Brugger et al., Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor gamma, J Immunol, vol.169, pp.1228-1235, 2002.

C. Faveeuw, S. Fougeray, V. Angeli, J. Fontaine, G. Chinetti et al.,

M. Maliszewski, B. Capron, M. Staels, F. Moser, and . Trottein, Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cells, FEBS Lett, vol.486, pp.261-266, 2000.

P. Gosset, A. S. Charbonnier, P. Delerive, J. Fontaine, B. Staels et al.,

. Trottein, Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells, Eur J Immunol, vol.31, pp.2857-2865, 2001.

L. Nagy, P. Tontonoz, J. G. Alvarez, H. Chen, and R. M. Evans, Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma, Cell, vol.93, pp.229-240, 1998.

S. S. Davies, A. V. Pontsler, G. K. Marathe, K. A. Harrison, R. C. Murphy et al., Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists, J Biol Chem, vol.276, pp.16015-16023, 2001.

L. Perrin-cocon, O. Diaz, M. Carreras, S. Dollet, A. Guironnet-paquet et al., High-density lipoprotein phospholipids interfere with dendritic cell Th1 functional maturation, Immunobiology, vol.217, pp.91-99, 2012.

G. K. Hansson and A. Hermansson, The immune system in atherosclerosis, Nat Immunol, vol.12, pp.204-212, 2011.

A. Niessner and C. M. Weyand, Dendritic cells in atherosclerotic disease, Clin Immunol, vol.134, pp.25-32, 2010.

S. Gupta, A. M. Pablo, X. Jiang, N. Wang, A. R. Tall et al., IFN-gamma potentiates atherosclerosis in ApoE knock-out mice, J Clin Invest, vol.99, pp.2752-2761, 1997.

J. Frostegard, A. K. Ulfgren, P. Nyberg, U. Hedin, J. Swedenborg et al.,

. Hansson, Cytokine expression in advanced human atherosclerotic plaques: dominance of proinflammatory (Th1) and macrophage-stimulating cytokines, Atherosclerosis, vol.145, pp.33-43, 1999.

S. Schulte, G. K. Sukhova, and P. Libby, Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis, Am J Pathol, vol.172, pp.1500-1508, 2008.

E. Laurat, B. Poirier, E. Tupin, G. Caligiuri, G. K. Hansson et al., In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein Eknockout mice, Circulation, vol.104, pp.197-202, 2001.

Z. Mallat, A. Gojova, V. Brun, B. Esposito, N. Fournier et al., Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice, Circulation, vol.108, pp.1232-1237, 2003.

S. A. Karabina, I. Brocheriou, G. L. Naour, M. Agrapart, H. Durand et al.,

. Ninio, Atherogenic properties of LDL particles modified by human group X secreted phospholipase A2 on human endothelial cell function, Faseb J, vol.20, pp.2547-2549, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00170587

M. Kimura-matsumoto, Y. Ishikawa, K. Komiyama, T. Tsuruta, M. Murakami et al.,

K. Akasaka, S. Ito, H. Ishiguro, S. Morita, T. Sato et al., Expression of secretory phospholipase A2s in human atherosclerosis development, Atherosclerosis, vol.196, pp.81-91, 2008.

K. Hanasaki, K. Yamada, S. Yamamoto, Y. Ishimoto, A. Saiga et al., Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation, J Biol Chem, vol.277, pp.29116-29124, 2002.

S. A. Karabina, S. Gora, R. Atout, and E. Ninio, Extracellular phospholipases in atherosclerosis, Biochimie, vol.92, pp.594-600, 2010.

S. Bezzine, R. S. Koduri, E. Valentin, M. Murakami, I. Kudo et al., Exogenously added human group X secreted phospholipase A(2) but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells, J Biol Chem, vol.275, pp.3179-3191, 2000.

A. G. Singer, F. Ghomashchi, C. L. Calvez, J. Bollinger, S. Bezzine et al., Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2, J Biol Chem, vol.277, pp.48535-48549, 2002.
URL : https://hal.archives-ouvertes.fr/hal-00090925

E. Valentin and G. Lambeau, Increasing molecular diversity of secreted phospholipases A(2) and their receptors and binding proteins, Biochim Biophys Acta, vol.1488, pp.59-70, 2000.

L. Perrin-cocon, S. Agaugue, F. Coutant, A. Masurel, S. Bezzine et al.,

. Lotteau, Secretory phospholipase A2 induces dendritic cell maturation, Eur J Immunol, vol.34, pp.2293-2302, 2004.
URL : https://hal.archives-ouvertes.fr/inserm-00136390

G. Giannattasio, D. Fujioka, W. Xing, H. R. Katz, J. A. Boyce et al., Group V secretory phospholipase A2 reveals its role in house dust mite-induced allergic pulmonary inflammation by regulation of dendritic cell function, J Immunol, vol.185, pp.4430-4438, 2010.

N. Kume, M. I. Cybulsky, and M. A. Gimbrone, Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells, J Clin Invest, vol.90, pp.1138-1144, 1992.

S. Gora, S. Maouche, R. Atout, K. Wanherdrick, G. Lambeau et al.,

. Karabina, Phospholipolyzed LDL induces an inflammatory response in endothelial cells through endoplasmic reticulum stress signaling, Faseb J, vol.24, pp.3284-3297, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00497550

G. J. Randolph, S. Beaulieu, S. Lebecque, R. M. Steinman, and W. A. Muller, Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking, Science, vol.282, pp.480-483, 1998.

M. Basaranoglu and G. Basaranoglu, Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis, World journal of gastroenterology : WJG, vol.17, pp.4055-4062, 2011.

V. Icard, O. Diaz, C. Scholtes, L. Perrin-cocon, C. Ramiere et al.,

P. Lotteau and . Andre, Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins, PLoS ONE, vol.4, p.4233, 2009.

M. Monazahian, I. Bohme, S. Bonk, A. Koch, C. Scholz et al., Low density lipoprotein receptor as a candidate receptor for hepatitis C virus, J Med Virol, vol.57, pp.223-229, 1999.

P. Andre, F. Komurian-pradel, S. Deforges, M. Perret, J. L. Berland et al.,

G. Brechot, V. Paranhos-baccala, and . Lotteau, Characterization of low-and very-low-density hepatitis C virus RNA-containing particles, J Virol, vol.76, pp.6919-6928, 2002.

D. Bradley, K. Mccaustland, K. Krawczynski, J. Spelbring, C. Humphrey et al., Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose, J Med Virol, vol.34, pp.206-208, 1991.

S. U. Nielsen, M. F. Bassendine, A. D. Burt, C. Martin, W. Pumeechockchai et al., Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients, J Virol, vol.80, pp.2418-2428, 2006.

S. U. Nielsen, M. F. Bassendine, C. Martin, D. Lowther, P. J. Purcell et al.,

. Toms, Characterization of hepatitis C RNA-containing particles from human liver by density and size, J Gen Virol, vol.89, pp.2507-2517, 2008.

R. Thomssen, S. Bonk, and A. Thiele, Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins, Med Microbiol Immunol, vol.182, pp.329-334, 1993.

O. Diaz, F. Delers, M. Maynard, S. Demignot, F. Zoulim et al., Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins, J Gen Virol, vol.87, pp.2983-2991, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00139590

C. Scholtes, C. Ramiere, D. Rainteau, L. Perrin-cocon, C. Wolf et al., High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients, Hepatology, vol.56, pp.39-48, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00683361

S. Agaugue, L. Perrin-cocon, P. Andre, and V. Lotteau, Hepatitis C lipo-Viro-particle from chronically infected patients interferes with TLR4 signaling in dendritic cell, PLoS ONE, vol.2, p.330, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00139931

S. Agaugue, L. Perrin-cocon, F. Coutant, P. Andre, and V. Lotteau, 1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity, J Immunol, vol.177, pp.2061-2071, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00137240

L. Perrin-cocon, S. Agaugue, O. Diaz, B. Vanbervliet, S. Dollet et al.,

V. Andre and . Lotteau, Th1 disabled function in response to TLR4 stimulation of monocyte-derived DC from patients chronically-infected by hepatitis C virus, PLoS ONE, vol.3, p.2260, 2008.